Siva Kolluri

Dr. Kolluri's research efforts are directed toward discovering molecular targets that are selective for cancer, developing agents that are selectively toxic to cancer cells, and devising optimal combinations of therapeutic agents aimed at different molecular pathways for the prevention and treatment of cancer. We are currently focusing our efforts in understanding the role of PER-ARNT-SIM (PAS) homology-domain proteins in carcinogenesis and developing small molecules to treat Bcl-2 overexpressing cancers. His group is also interested in AhR-mediated actions in cancer, in the immune system.

TECHNOLOGIES
10-chloro-BBQ for the prevention of progression of type I diabetes
Anti-cancer Compounds
SECTORS
Earth Ecosystems
Health and Wellness
Innovation and Prosperity
CATEGORIES
Agricultural
Biological Materials
Chemical
Chemistry
Device
Diagnostics
Education & Training
Engineering
Imaging
Information Technology
Materials Science
Medical
Medical Devices
Nanoscience & Microtechnologies
Physical Science
Research Tools
Software
Sustainability & Cleantechnologies
Therapeutics
Transportation
Vaccines
© 2017. All Rights Reserved. Powered by Inteum